<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f1 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f2 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff10; src: url("10.ttf"); }
#f3 { font-family:ff10,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url("3.ttf"); }
#f4 { font-family:ff3,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff9; src: url("9.ttf"); }
#f5 { font-family:ff9,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
#f6 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
#f7 { font-family:ff1,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="842" src="page3.png">
<div class="txt" style="position:absolute; left:427px; top:54px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">삼성바이오로직스(207940)</span></div>
<div class="txt" style="position:absolute; left:189px; top:102px;"><span id="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">&lt;</span><span id="f1" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">표 </span><span id="f4" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">4&gt; DCF valuation</span></div>
<div class="txt" style="position:absolute; left:189px; top:118px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">세부항목</span></div>
<div class="txt" style="position:absolute; left:189px; top:129px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">debt/equity</span></div>
<div class="txt" style="position:absolute; left:189px; top:141px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">시장위험프리미엄</span></div>
<div class="txt" style="position:absolute; left:189px; top:152px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">무위험자산수익률</span></div>
<div class="txt" style="position:absolute; left:189px; top:163px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">타인자본비용(Cost of debt)</span></div>
<div class="txt" style="position:absolute; left:189px; top:175px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자기자본비용 (Cost of equity)</span></div>
<div class="txt" style="position:absolute; left:189px; top:186px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">WACC</span></div>
<div class="txt" style="position:absolute; left:189px; top:198px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">영구가치(Terminal value)</span></div>
<div class="txt" style="position:absolute; left:189px; top:209px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">영구성장률(Terminal growth rate)</span></div>
<div class="txt" style="position:absolute; left:189px; top:220px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">현금흐름의 영구가치(Estimated terminal FCF, 십억원)</span></div>
<div class="txt" style="position:absolute; left:189px; top:231px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">영구가치의 NPV(십억원, 2022 년 12 월 31 일 기준)</span></div>
<div class="txt" style="position:absolute; left:189px; top:243px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">영구가치의 NPV(십억원, 2017 년 10 월 26 일 기준)</span></div>
<div class="txt" style="position:absolute; left:189px; top:255px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">DCF valuation</span></div>
<div class="txt" style="position:absolute; left:189px; top:266px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">NPV of Forecasts(십억원)</span></div>
<div class="txt" style="position:absolute; left:189px; top:277px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">NPV of Terminal Value(십억원)</span></div>
<div class="txt" style="position:absolute; left:189px; top:288px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">+ 삼성바이오에피스 지분가치(2Q17 기준 94.6%)</span></div>
<div class="txt" style="position:absolute; left:196px; top:300px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Archizen Bioech(50%)</span></div>
<div class="txt" style="position:absolute; left:189px; top:311px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">기업가치(십억원)</span></div>
<div class="txt" style="position:absolute; left:189px; top:323px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">+ 2017 년 예상 순현금 + 콜옵션 행사금(십억원)</span></div>
<div class="txt" style="position:absolute; left:189px; top:334px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">지분가치(Equity value, 십억원)</span></div>
<div class="txt" style="position:absolute; left:189px; top:345px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">주식수 (백만주)</span></div>
<div class="txt" style="position:absolute; left:189px; top:357px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">주당가치 (원)</span></div>
<div class="txt" style="position:absolute; left:189px; top:371px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료</span><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">: </span><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">한국투자증권</span></div>
<div class="txt" style="position:absolute; left:510px; top:104px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(단위: %)</span></div>
<div class="txt" style="position:absolute; left:523px; top:129px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">13.4</span></div>
<div class="txt" style="position:absolute; left:526px; top:141px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">7.0</span></div>
<div class="txt" style="position:absolute; left:526px; top:152px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2.3</span></div>
<div class="txt" style="position:absolute; left:526px; top:163px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2.3</span></div>
<div class="txt" style="position:absolute; left:526px; top:175px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">9.3</span></div>
<div class="txt" style="position:absolute; left:526px; top:186px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">8.2</span></div>
<div class="txt" style="position:absolute; left:526px; top:209px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">5.0</span></div>
<div class="txt" style="position:absolute; left:518px; top:220px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,164</span></div>
<div class="txt" style="position:absolute; left:514px; top:231px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">35,841</span></div>
<div class="txt" style="position:absolute; left:514px; top:243px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">23,765</span></div>
<div class="txt" style="position:absolute; left:519px; top:267px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2,282</span></div>
<div class="txt" style="position:absolute; left:515px; top:278px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">23,765</span></div>
<div class="txt" style="position:absolute; left:519px; top:290px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2,525</span></div>
<div class="txt" style="position:absolute; left:529px; top:301px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">14</span></div>
<div class="txt" style="position:absolute; left:515px; top:311px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">28,585</span></div>
<div class="txt" style="position:absolute; left:525px; top:323px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">538</span></div>
<div class="txt" style="position:absolute; left:515px; top:334px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">29,123</span></div>
<div class="txt" style="position:absolute; left:522px; top:345px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">66.2</span></div>
<div class="txt" style="position:absolute; left:511px; top:357px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">440,159</span></div>
<div class="txt" style="position:absolute; left:189px; top:411px;"><span id="f7" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">기업개요 및 용어해설</span></div>
<div class="txt" style="position:absolute; left:189px; top:428px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2011년 4월 설립되어 2016년 11월 코스피에 상장한 삼성그룹 산하의 동물세포배양타입의 바이오의약품 CMO(Contract</span></div>
<div class="txt" style="position:absolute; left:189px; top:440px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Manufacturing Organization, 의약품 위탁생산 사업)업체이다. 2016년 기준 매출의 100%가 CMO사업에서 발생했다.</span></div>
<div class="txt" style="position:absolute; left:189px; top:452px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">주요주주는 삼성물산(43.4%)과 삼성전자(31.5%)이다. 주요 고객사는 글로벌 제약업체들인 Bristol-Myers</span></div>
<div class="txt" style="position:absolute; left:189px; top:464px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Squibb(BMS), Roche 등이며 Merck와 Biogen을 협력 파트너로 보유하고 있다</span></div>
<div class="txt" style="position:absolute; left:533px; top:795px;"><span id="f2" style="font-size:9px;vertical-align:baseline;color:rgba(127,127,127,1);">3</span></div>
</body>
</html>
